Small molecule high throughput screen using AstraZeneca facilities

Support for academic researchers to conduct high-throughput screening using AstraZeneca’s compound library and screening infrastructure. The January 2027 round is open to all targets and provides awards up to GBP270,000. Projects must be directed by an eligible research lead actively engaged in the work. Commercial-led applications and collaborations involving additional commercial parties are excluded. Apply through UKRI’s Funding Service by 28 January 2027 at 16:00 UK time.

Organisations with standard MRC eligibility; normally UK-based project leads, with the stated MRC Gambia and Uganda unit exceptions. One application per project lead; source rules restrict resubmissions.